ALS
-
ALS, Alzheimer’s, Brain, frontotemporal dementia, microglia, neurodegeneration, Neurodegenerative Diseases, neuroscience, Parkinsons, single-nucleus RNA sequencing, SPP1SPP1 Marks Cross-Disease Microglial Activation in Neurodegeneration
A 2026 Glia analysis found a shared microglial transcriptional program across 5…
-
AB10015, ALS, ALS survival, ALSFRS-R, amyotrophic lateral sclerosis, Drugs, ENCALS, masitinib, mast cells, microglia, motor neuron disease, Neurodegenerative Diseases, neuroscience, riluzole, tyrosine kinase inhibitorMasitinib for ALS: AB10015 Reports 42.3% 5-Year Survival
A 2026 AB10015 post-hoc preprint reported 42.3% 5-year survival from amyotrophic lateral…
-
ALS, Brain, cerebral palsy, digital biomarkers, dysarthria, HuBERT, motor speech disorder, Neurodegenerative Diseases, neuroscience, parkinson’s disease, phonological subspaces, speech AI, speech biomarkerDysarthria Speech Biomarker Tracked Severity Across 5 Languages
A 2026 medRxiv preprint found that a training-free speech biomarker tracked dysarthria…
-
ALS, ALSFRS, ALSFRS-R, amyotrophic lateral sclerosis, clinical trial endpoints, functional decline, motor neuron disease, Neurodegenerative Diseases, neuroscience, ordinal outcome scales, PRO-ACT, Psychiatry, Psychology, Shannon entropy, Simpson’s paradoxALS Entropy Analysis Finds 5-Month Signal Hidden by ALSFRS Scores
A 2026 PRO-ACT analysis of amyotrophic lateral sclerosis (ALS) trial data found…
